What does this research mean for the field?

Sarcopenia-associated CD8+ T-cell reconstitution predicts poor clinical outcomes in patients with severe aplastic anemia following hematopoietic stem cell transplantation. Novelty: ClaimNovelty.INCREMENTAL. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

To assess the relationship between sarcopenia-associated CD8+ T-cell reconstitution and clinical outcomes in severe aplastic anemia after hematopoietic stem cell transplantation.

June 1, 2026Open Access

Sarcopenia-associated CD8+ T-cell reconstitution predicts poor outcomes in severe aplastic anemia after hematopoietic stem cell transplantation

Key Points

To assess the relationship between sarcopenia-associated CD8+ T-cell reconstitution and clinical outcomes in severe aplastic anemia after hematopoietic stem cell transplantation.
Evaluated CD8+ T-cell levels in severe aplastic anemia patients post-HSCT
Assessed clinical outcomes based on T-cell reconstitution data
Lower CD8+ T-cell reconstitution correlated with adverse clinical outcomes
Observations suggest a predictive role of CD8+ T-cells in post-transplant prognosis

Abstract

T cells following HSCT in SAA patients, potentially improving posttransplant clinical outcomes.

Demander à l'IA

Bookmark

View Full Paper

Cite This Study

Chen et al. (Fri,) studied this question.

synapsesocial.com/papers/6a1d21ba02fbce9130637a5d https://doi.org/https://doi.org/10.1007/s00277-026-07093-y

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

Demander à l'IA

Bookmark

View Full Paper